InspireMD（纽约证券交易所代码：NSPL）与社会资本Suvretta Holdings Corp. I（纳斯达克股票代码：DAAA）财务调查

InspireMD (NYSE:NSPR – Get Rating) and Social Capital Suvretta Holdings Corp. I (NASDAQ:DNAA – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, risk, dividends and analyst recommendations.

Profitability

This table compares InspireMD and Social Capital Suvretta Holdings Corp. I's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current recommendations for InspireMD and Social Capital Suvretta Holdings Corp. I, as provided by MarketBeat.

Risk and Volatility

InspireMD has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500. Comparatively, Social Capital Suvretta Holdings Corp. I has a beta of -0.02, indicating that its share price is 102% less volatile than the S&P 500.

Insider & Institutional Ownership

2.1% of InspireMD shares are owned by institutional investors. 3.8% of InspireMD shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares InspireMD and Social Capital Suvretta Holdings Corp. I's gross revenue, earnings per share and valuation.

Social Capital Suvretta Holdings Corp. I has lower revenue, but higher earnings than InspireMD.

About InspireMD

(Get Rating)

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

About Social Capital Suvretta Holdings Corp. I

(Get Rating)

Social Capital Suvretta Holdings Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology industry. The company was incorporated in 2021 and is based in Henderson, Nevada.

Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.